(0.06%) 5 311.50 points
(0.07%) 40 173 points
(0.10%) 18 523 points
(1.68%) $82.72
(0.12%) $1.720
(0.85%) $2 231.50
(-0.08%) $24.73
(0.49%) $914.20
(0.33%) $0.926
(0.57%) $10.83
(0.10%) $0.792
(-0.08%) $92.37
Live Chart Being Loaded With Signals
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas...
Stats | |
---|---|
Today's Volume | 4.33M |
Average Volume | 1.75M |
Market Cap | 2.27B |
EPS | $0 ( 2024-03-14 ) |
Next earnings date | ( $0 ) 2024-05-10 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -21.91 |
ATR14 | $0.513 (1.08%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-08-09 | Ra Capital Management, L.p. | Sell | 786 407 | Common Stock |
2023-08-09 | Ra Capital Management, L.p. | Sell | 21 250 | Stock Option (Right to Buy) |
2023-08-09 | Tetlow Sharon | Sell | 49 841 | Common Stock |
2023-08-09 | Tetlow Sharon | Sell | 13 800 | Stock Option (right to buy) |
2023-08-09 | Tetlow Sharon | Sell | 21 250 | Stock Option (right to buy) |
INSIDER POWER |
---|
-53.87 |
Last 99 transactions |
Buy: 13 025 781 | Sell: 10 716 392 |
Volume Correlation
DICE Therapeutics, Inc. Correlation
10 Most Positive Correlations | |
---|---|
MRNS | 0.883 |
DGNU | 0.879 |
ABCM | 0.863 |
ABEO | 0.86 |
SKYW | 0.86 |
SINO | 0.859 |
FSFG | 0.858 |
CGNT | 0.858 |
DFH | 0.855 |
IRBT | 0.851 |
10 Most Negative Correlations | |
---|---|
WYNN | -0.869 |
MCFT | -0.869 |
LIBY | -0.867 |
LSCC | -0.866 |
ASUR | -0.865 |
TGLS | -0.864 |
ULTA | -0.863 |
KYCH | -0.863 |
ARYD | -0.863 |
LAKE | -0.863 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
DICE Therapeutics, Inc. Correlation - Currency/Commodity
DICE Therapeutics, Inc. Financials
Annual | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-2.07 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.740 |
Q1 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.420 |
Q4 | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.500 |
Financial Reports:
No articles found.
DICE Therapeutics, Inc.
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lead therapeutic candidate is DC-806, an oral antagonist of the pro-inflammatory signaling molecule, interleukin-17, which is a validated drug target implicated in a various immunology indications. It is also developing oral therapeutic candidates targeting a4ß7 integrin for the treatment of inflammatory bowel diseases, as well as targeting aVß1/aVß6 integrin for the treatment of idiopathic pulmonary fibrosis. In addition, the company focuses on immuno-oncology for antibody therapeutics. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators